Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis

Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

Erik von Elm, Douglas G. Altman, Matthias Egger et al. · BMJ · 2007 · 10.1K citations · Full text

Public Health, Public Health Practice, Clinical Epidemiology +10

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

William J. Sandborn, Chinyu Su, Bruce E. Sands et al. · New England Journal of Medicine · 2017 · 1.7K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis

William J. Sandborn, Subrata Ghosh, Julián Panés et al. · New England Journal of Medicine · 2012 · 799 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

The Incidence of Deep Venous Thrombosis and Pulmonary Embolism among Patients with Inflammatory Bowel Disease: A Population-based Cohort Study

Thrombosis and Haemostasis · 2001 · 577 citations

Medicine, Internal Medicine, Clinical Epidemiology +15

Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials

William J. Sandborn, Julián Panés, Geert D’Haens et al. · Clinical Gastroenterology and Hepatology · 2018 · 244 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9